Research presented at the Alzheimer’s Association International Conference 2025 provides new insight into the many factors impacting brain health – from environmental risks and medication use to lifestyle and genetics. As a caregiver for one of the 7.2 million Americans living with dementia, including 22,300 Delawareans, I am grateful for the meaningful progress being made against this devastating disease.
My husband, Timothy, was diagnosed with frontotemporal dementia at age 56. Changes have come fast since his diagnosis just two years ago. Tim was forced to leave his job many years before retirement age, and we have incurred caregiving expenses that add to the burden of being a one-income household. Tim now requires 24-7 care. My concerns are many, as our future is uncertain.
Research presented at the conference shows that when we invest in dementia research, we accelerate scientific progress and discover valuable insights that could make a real difference for families like mine in Delaware – and across the nation.
Thankfully, over the last decade, Congress has made addressing dementia a priority. As the prevalence and cost of this devastating disease continue to grow annually, continued investment in research must remain a priority.
Join me and the Alzheimer’s Association and ask Sen. Chris Coons, Sen. Lisa Blunt Rochester and Congresswoman Sarah McBride to support continued investment in Alzheimer’s and dementia research.